A carregar...
Characterizing the original anti‐C5 function‐blocking antibody, BB5.1, for species specificity, mode of action and interactions with C5
The implication of complement in multiple diseases over the last 20 years has fuelled interest in developing anti‐complement drugs. To date, the focus has been on C5; blocking cleavage of C5 prevents formation of two pro‐inflammatory activities, C5a anaphylatoxin and membrane attack complex. The con...
Na minha lista:
| Publicado no: | Immunology |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7496778/ https://ncbi.nlm.nih.gov/pubmed/32557571 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/imm.13228 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|